Simris Group B
SIMRIS BAlgoritmens signaler
- ›Starkt 3m-momentum (+26.6%)
- ›Starkt 6m-momentum (+37.7%)
- ›Pris över MA50 och MA200 (uppåttrend)
- ›Hög volatilitet (117% årlig)
- ›+197% från 52v-botten
- ›-39% från 52v-toppen
📰 Senaste nyheter & analys
Källor: Placera, Nyhetsbyrån Direkt, Google NewsSIMRIS GROUP CONFIRMS STRATEGIC DIRECTION AND ADVANCES TWO AMANITIN-BASED ADC PROGRAMS TOWARD THE CLINIC
2026-09-08Simris Group AB (publ) (“Simris” or the “Company”) confirms its strategy to develop amanitin-derived novel payloads to overcome treatment resistance in both liquid and solid tumors. Under strengthened
Simris GroupMFNEBITDA-FÖRLUSTEN MINSKADE 2 KV
2026-08-12STOCKHOLM (Nyhetsbyrån Direkt) Simris Group, ett bioteknikbolag som utvecklar ingredienser från mikroalger, redovisar intäkter på 0,2 miljoner kronor (0,7) och ett ebitda-resultat om -1,9 miljoner kro
SIMRISNyhetsbyrån DirektSIMRIS GROUP INTERIM REPORT JANUARY-JUNE 2026
2026-08-12QUARTER 2, APRIL – JUNE 2026Net revenue decreased by 71% to SEK 196k (687k). EBITDA improved by 35% to SEK -1 927k (-2 980k). EBIT/Operating result improved by 19% to SEK –5 437k (–6 693k). INTERIM PE
Simris GroupMFNSIMRIS GROUP APPOINTS BIOTECHNOLOGY EXPERT DR. TIFFANY J. VORA AS STRATEGIC ADVISOR
2026-07-28Simris Group AB today announced the appointment of Dr. Tiffany J. Vora as a Strategic Advisor. Dr. Vora is a biotechnology scientist, entrepreneur, educator, and advisor with experience across molecu
Simris GroupMFNSIMRIS GROUP AB APPOINTS ADC EXPERT PROFESSOR ANDREAS PAHL AS CHIEF EXECUTIVE OFFICER OF ITS SUBSIDIARY SIMRIS BIOLOGICS GMBH
2026-07-15Simris Group AB (SIMRIS B) today announced the appointment of Professor Andreas Pahl as Chief Executive Officer of Simris Biologics GmbH, its wholly owned subsidiary based in Berlin, Germany. Professo
Simris GroupMFNA holder of warrants in Simris Group AB (publ) has declared his intention to exercise 3.3 million warrants amounting to total proceeds of EUR 15,000
2026-07-13Simris Group AB (publ) ("Simris Group" or the "Company") has today received information from a holder of warrants of series 2026/2027 in Simris Group that he intends to exercise 3.3 million warrants a
Simris GroupMFNHolders of warrants in Simris Group AB (publ) have declared their intention to exercise 220 million warrants amounting to total proceeds of MEUR 1
2026-07-06Simris Group AB (publ) ("Simris Group" or the "Company") has today received information from certain holders of warrants of series 2025/2027 and series 2026/2027 in Simris Group that they intend to ex
Simris GroupMFNBulletin from Simris Group AB’s annual general meeting
2026-06-24Simris Group AB (publ), reg. no. 556841–9187 (the "Company"), held its annual general meeting on 24 June 2026. Below follows a summary of the resolutions that were passed at the general meeting Income
Simris GroupMFNNeogap Therapeutics | Global Forum 2026
2026-05-25BioStock har just publicerat Neogap Therapeutics | Global Forum 2026.
Simris GroupBioStockSimris Group | Global Forum 2026
2026-05-25BioStock har just publicerat Simris Group | Global Forum 2026.
Simris GroupBioStockCorrection: Notice of the Annual General Meeting of Simris Group AB (publ)
2026-05-21Wrong headline. English version follow after the Swedish version. Kallelse till årsstämma i Simris Group AB (publ) Aktieägarna i Simris Group AB (publ), org.nr 556841-9187 (”Bolaget”), kallas härmed t
Simris GroupMFNNotice of Extraordinary General Meeting of Simris Group AB (publ)
2026-05-21English version follow after the Swedish version. Kallelse till årsstämma i Simris Group AB (publ) Aktieägarna i Simris Group AB (publ), org.nr 556841-9187 (”Bolaget”), kallas härmed till årsstämma de
Simris GroupMFNGlobal Forum Live Stream
2026-05-21BioStock har just publicerat Global Forum Live Stream.
BioInvent InternationalBioStockEBITDA-FÖRLUSTEN MINSKADE 1 KV
2026-05-13STOCKHOLM (Nyhetsbyrån Direkt) Simris Group, ett bioteknikbolag som utvecklar ingredienser från mikroalger, redovisar intäkter på 0,4 miljoner kronor (0,2) och ett ebitda-resultat om -2,2 miljoner kro
SIMRISNyhetsbyrån DirektSIMRIS GROUP INTERIM REPORT JANUARY-MARCH 2026
2026-05-13QUARTER 1, JANUARY – MARCH 2026Net revenue increased by 167% to SEK 424k (159k). EBITDA improved by 41% to SEK -2 183k (-3 724k). EBIT/Operating result improved by 23% to SEK –5 626k (–7 288k). KEY EV
Simris GroupMFNAVSIKTSAVTAL MED YTTERLIGARE POTENTIELL KÖPARE AV ANLÄGGNING
2026-05-12STOCKHOLM (Nyhetsbyrån Direkt) Simris Group har ingått ett avsiktsavtal med en andra potentiell köpare av bolagets mikroalgsproduktionsanläggning i svenska Hammenhög.Det framgår av ett pressmeddelande
SIMRISNyhetsbyrån Direkt
Klicket på "Köp i Nordnet" öppnar din Nordnet-app om installerad — där loggar du in med BankID. Annars öppnas Nordnets webbsajt där du kan logga in med BankID på samma sätt.